000 01546nam  2200337zi 4500
0019.940307
003CaOODSP
00520240712143159
006m     o  d f      
007cr |n|||||||||
008240709e20130913onc     ob   f00| 0 eng d
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH14-633/2013E-PDF
24500|aReview of Health Canada's actions in the recall of Alysena 28 : |bfinal report / |cRisk Sciences International.
24617|aFinal report : |breview of the recall of Alysena 28
264 1|a[Ottawa] : |bHealth Canada, |cSeptember 13, 2013.
300 |a1 online resource (1 volume (various pagings))
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Examen des mesures prises par Santé Canada dans le cadre du rappel d’Alysena 28.
500 |aTitle appears with a trademark symbol after the word “Alysena.”
500 |aPrepared for: Health Canada.
504 |aIncludes bibliographical references (pages 33-34).
650 0|aOral contraceptives|zCanada.
650 0|aPharmaceutical industry|zCanada|xQuality control.
7101 |aCanada. |bHealth Canada, |eissuing body.
7101 |aRisk Sciences International, |econsultant.
77508|tExamen des mesures prises par Santé Canada dans le cadre du rappel d’Alysena 28 / |w(CaOODSP)9.940551
85640|qPDF|s2.18 MB|uhttps://publications.gc.ca/collections/collection_2024/sc-hc/H14-633-2013-eng.pdf